Live feed/
Filings
/
SCHEDULE 13D/A
/
0001213900-26-064716
Stake: 7.40%
Shares: 450,313
CUSIP: 73017P508
Class: Common Stock, $0.0001 par value per share
Item 4 — Purpose of Transaction
Since the filing of the Reporting Persons' Schedule 13D with the SEC on March 28, 2025, the Common Stock reported therein were assigned from Mr. Lichti's entities to Northstrive Companies Inc. The Issuer underwent multiple reverse stock splits since the filing of the Schedule 13D, and the beneficially owned amounts of Common Stock reported in this Amendment No. 1 reflects shares on a post-split basis. On June 1, 2026 the Issuer granted to Northstrive Companies options reported herein, pursuant to the Issuer's 2025 Equity Incentive Plan, as amended, and as parital consideration for consultant services provided to the Issuer through Northstrive Companies Inc.
Cross-References
Insider Activity (last 365d)
1 transaction
1 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-07-15
DTC 1.00
809,201 shares short · +144.4% vs prior
Post-Filing Returns · since 2026-06-01 on ELAB
Anchor price 1.77 on closest trading day on/after 2026-06-01. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
| 2026-06-01 |
Daley Juliana |
director |
Award |
75,046 |
$1.77 |
$133K |
Other 13D/G Filings on PMGC Holdings Inc.
| Filed | Form | Filer | Stake | Shares | |
| 2026-06-03 |
SCHEDULE 13D |
Bensler Graydon |
7.40% |
450,287 |
view → |
Other Filings by Braeden Lichti
| Filed | Form | Issuer | Stake | Shares | |
| 2026-06-02 |
SCHEDULE 13D/A |
Bluejay Diagnostics, Inc. BJDX |
— |
0 |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →